Eli Lilly and Company India Pvt Ltd
Tirzepatide (5mg)
Mounjaro 5mg Solution for Injection 0.5 ml is used to improve blood sugar control in adults with type 2 diabetes mellitus. It contains Tirzepatide and is given as an injection under the skin.
Injection
Mounjaro 5mg Solution for Injection 0.5 ml is an antidiabetic medicine used to improve blood sugar control in adults with type 2 diabetes mellitus. It is given as an injection under the skin and is used along with diet and exercise.
Mounjaro 5mg Solution for Injection 0.5 ml should be injected under the skin (subcutaneously) in the abdomen, thigh, or upper arm as directed by your doctor. Rotate the injection site with each dose. Do not inject into a vein or muscle.
Nausea Vomiting Diarrhea Decreased appetite Indigestion Constipation
It is advisable to avoid or limit alcohol consumption while using this medicine as it may increase the risk of low blood sugar (hypoglycemia).
It is not known if Mounjaro 5mg Solution for Injection 0.5 ml passes into breast milk. Consult your doctor before breastfeeding while using this medicine.
Mounjaro 5mg Solution for Injection 0.5 ml is not recommended during pregnancy unless clearly needed. Consult your doctor before use.
Insulin Sulfonylureas Other antidiabetic medicines
Mounjaro 5mg Solution for Injection 0.5 ml contains Tirzepatide, which acts as a dual GIP and GLP-1 receptor agonist. It helps the pancreas release insulin, reduces the amount of sugar produced by the liver, and slows down the absorption of sugar from the gut.
Take the medicine at the same time each week. Do not stop taking the medicine without consulting your doctor. Maintain a healthy diet and exercise regularly for better results.
Mounjaro 5mg Solution for Injection 0.5 ml is used to improve blood sugar (glucose) levels in adults with type 2 diabetes mellitus. It is given as an injection under the skin (subcutaneous injection) and is used along with diet and exercise to improve glycemic control.
Mounjaro 5mg Solution for Injection 0.5 ml contains Tirzepatide, which acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It helps the pancreas release insulin, reduces the amount of sugar produced by the liver, and slows down the absorption of sugar from the gut.
Mounjaro 5mg Solution for Injection 0.5 ml should be injected under the skin (subcutaneously) in the abdomen, thigh, or upper arm as directed by your doctor. Do not inject into a vein or muscle. Rotate the injection site with each dose to reduce the risk of lipodystrophy (skin changes).
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time.
Mounjaro 5mg Solution for Injection 0.5 ml is not recommended during pregnancy unless clearly needed. Consult your doctor before using this medicine if you are pregnant or planning to become pregnant.